Century-Old Method Revives Hope for Metastatic Ovarian Cancer Treatment
Researchers at the Wistar Institute have developed a novel treatment for metastatic ovarian cancer that activates myeloid cells in the peritoneal cavity using a combination of beta-glucan and interferon-gamma. This approach, inspired by early 20th-century methods, has shown promising results in preclinical models, significantly reducing tumor size and overcoming chemotherapy resistance. The findings, published in The Journal of Experimental Medicine, suggest a potential new method for treating this aggressive cancer.
